NCT03315221 - Renoir: A Randomised, Double-blind, Controlled Trial to Evaluate the Effects of a New Human Milk Fortifier on Growth and Tolerance in Preterm Infants. | Biotech Hunter

Enrollment

207

Participants

Timeline

Start Date

March 8, 2018

Primary Completion Date

June 1, 2020

Study Completion Date

September 21, 2022

Conditions

Subjects in Need of a Human Milk Fortifier (HMF)GrowthToleranceSafety

Interventions

OTHER

Test product

HMF with added lipids - Intervention group

OTHER

Control product

Commercially available HMF (without lipids) - control group

Trial Locations (15)

Hôpital de la Croix Rousse, Lyon

CHRU Nancy - Maternité regionale Universitaire A. Pinard, Nancy

Universitätskinderklinik der Otto-v.-Guericke Universität, Magdeburg

Klinikum Nürnberg Süd, Nuremberg

Noordwest Ziekenhuisgroep, Alkmaar

Ziekenhuisgroep Twente, Almelo

Flevoziekenhuis, Almere Stad

Amsterdam UMC (VUMC), Amsterdam

OLVG Onze Lieve Vrouwe Gasthuis, Amsterdam

Spaarne Ziekenhuis, Hoofddorp

Maastricht UMC, Maastricht

VieCuri Medisch Centrum, Venlo

Isala Ziekenhuis, Zwolle

Saint-Peter's Hospital NHS Foundation Trust, Chertsey

Norfolk and Norwich NHS Foundation Trust, Norwich